Targeting of bmi-1 with ptc-209 shows potent anti-myeloma activity and impairs the tumour microenvironment
HIGHLIGHTS who: Arnold Bolomsky from the Wilhelminenspital, Montleartstraße, Vienna, Austria have published the research: Targeting of BMI-1 with PTC-209 shows […]